Possible cyclosporin-danazol interaction in a patient with aplastic anaemia

Am J Hematol. 1999 Sep;62(1):63-4. doi: 10.1002/(sici)1096-8652(199909)62:1<63::aid-ajh15>3.0.co;2-r.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adult
  • Anemia, Aplastic / drug therapy*
  • Cyclosporine / administration & dosage
  • Cyclosporine / blood
  • Cyclosporine / pharmacokinetics*
  • Cyclosporine / therapeutic use
  • Cytochrome P-450 Enzyme Inhibitors
  • Danazol / administration & dosage
  • Danazol / pharmacology
  • Danazol / therapeutic use*
  • Drug Monitoring
  • Drug Synergism
  • Drug Therapy, Combination
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / therapeutic use*
  • Inactivation, Metabolic
  • Male

Substances

  • Cytochrome P-450 Enzyme Inhibitors
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Cyclosporine
  • Danazol